Irish Medical Times·3 min read·medium
Genomic-based testing to transform care for multiple myeloma patients in Ireland
M
Michael McHale
✦AI Summary
Beaumont Hospital in Dublin has launched Ireland's first genomics-based prognostic testing service for multiple myeloma patients. The program uses gene expression profiling and next-generation sequencing to provide personalized treatment plans and improve patient quality of life.
The country’s first genomics-based prognostic testing for multiple myeloma will provide clinicians with a better understanding of how patients are likely respond to personalised treatments, writes Michael McHale
healthsciencetechnology
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in